+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

COSMOS Pharmaceutical Corp (3349) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 32 Pages
  • September 2023
  • GlobalData
  • ID: 5483738
COSMOS Pharmaceutical Corp (3349) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

COSMOS Pharmaceutical Corp (COSMOS) is a retailer of pharmaceutical products. The company sells a range of general food, sundry goods, pharmaceutical and cosmetics products. It offers products and services under private brands such as ON365, Standard Day, delicious side dishes and Antellige EX. The company sells products online through shop.cosmospc.co.jp and third party platform, amazon. It operates through subsidiaries Green Flash Co., Ltd. and Cosmos Corporation Co., Ltd. The company sells its products in Nagasaki Prefecture, Saga Prefecture, Fukuoka Prefecture, Yamaguchi Prefecture, Shimane Prefecture, Okayama Prefecture, Hiroshima, Tottori Prefecture and Hyogo Prefecture among all. COSMOS is headquartered in Fukuoka City, Fukuoka, Japan.

COSMOS Pharmaceutical Corp Key Recent Developments

  • Jan 16, 2023: COSMOS Pharmaceutical Announces Consolidated Financial Results for the Six Months Ended November 30, 2022

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • COSMOS Pharmaceutical Corp - Key Facts
  • COSMOS Pharmaceutical Corp - Key Employees
  • COSMOS Pharmaceutical Corp - Key Employee Biographies
  • COSMOS Pharmaceutical Corp - Major Products and Services
  • COSMOS Pharmaceutical Corp - History
  • COSMOS Pharmaceutical Corp - Company Statement
  • COSMOS Pharmaceutical Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • COSMOS Pharmaceutical Corp - Business Description
  • Product Category: Cosmetics
  • Performance
  • Product Category: General Foods
  • Performance
  • Product Category: Others
  • Performance
  • Product Category: Pharmaceutical
  • Performance
  • Product Category: Sundry Goods
  • Performance
  • COSMOS Pharmaceutical Corp - Corporate Strategy
  • COSMOS Pharmaceutical Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • COSMOS Pharmaceutical Corp - Strengths
  • COSMOS Pharmaceutical Corp - Weaknesses
  • COSMOS Pharmaceutical Corp - Opportunities
  • COSMOS Pharmaceutical Corp - Threats
  • COSMOS Pharmaceutical Corp - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Recent Developments
  • Jan 16, 2023: COSMOS Pharmaceutical Announces Consolidated Financial Results for the Six Months Ended November 30, 2022
Section 5 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • COSMOS Pharmaceutical Corp, Key Facts
  • COSMOS Pharmaceutical Corp, Key Employees
  • COSMOS Pharmaceutical Corp, Key Employee Biographies
  • COSMOS Pharmaceutical Corp, Major Products and Services
  • COSMOS Pharmaceutical Corp, History
  • COSMOS Pharmaceutical Corp, Subsidiaries
  • COSMOS Pharmaceutical Corp, Key Competitors
  • COSMOS Pharmaceutical Corp, Ratios based on current share price
  • COSMOS Pharmaceutical Corp, Annual Ratios
  • COSMOS Pharmaceutical Corp, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • COSMOS Pharmaceutical Corp, Performance Chart (2019 - 2023)
  • COSMOS Pharmaceutical Corp, Ratio Charts

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Create SD Holdings Co Ltd
  • Ain Holdings Inc
  • Sugi Holdings Co Ltd
  • Genky Stores Inc
  • Cawachi Ltd
  • Welcia Holdings Co Ltd